Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.070
+0.020 (1.90%)
Oct 17, 2025, 4:00 PM EDT - Market closed
Dyadic International Market Cap
Dyadic International has a market cap or net worth of $38.72 million as of October 17, 2025. Its market cap has increased by 27.37% in one year.
Market Cap
38.72M
Enterprise Value
38.80M
1-Year Change
27.37%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since April 18, 2019, Dyadic International's market cap has decreased from $94.80M to $38.72M, a decrease of -59.16%. That is a compound annual growth rate of -12.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 38.70M | -25.29% |
| Dec 31, 2024 | 51.80M | 11.64% |
| Dec 29, 2023 | 46.40M | 32.19% |
| Dec 30, 2022 | 35.10M | -72.34% |
| Dec 31, 2021 | 126.90M | -14.20% |
| Dec 31, 2020 | 147.90M | 4.89% |
| Dec 31, 2019 | 141.00M | 48.73% |
| Apr 18, 2019 | 94.80M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.59B |
| Johnson & Johnson | 462.69B |
| AbbVie | 400.78B |
| UnitedHealth Group | 323.03B |
| AstraZeneca | 261.44B |
| Novo Nordisk | 254.14B |
| Novartis AG | 253.93B |
| Abbott Laboratories | 222.13B |